JL Pharma SRL
JL Pharma reported total assets of 22,608 € at the end of the 2025 financial year (annual accounts filed with the NBB on 18 Jun 2026).
The score of JL Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -57 % Total assets -51 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
JL Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Jun 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
- Year ended 31 Dec 2023filed on 02 Jul 2024
- Year ended 31 Dec 2022filed on 03 Jul 2023
- Year ended 31 Dec 2021filed on 11 Jul 2022
JL Pharma's financial analysis
- Solvency47.5%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of JL Pharma
JL Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0743.926.553
- VAT number
- BE0743926553
- Peppol
- Registered · 0208:0743926553 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Feb 2020
- Registered office
- 4987 Stoumont
- Latest accounts
- 2025 · filed on 18 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
JL Pharma (SRL) has been based in Stoumont since 2020, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 5,740 € and equity of 10,746 €; its revenue is not published. Its solvency stands at 47.5%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to JL Pharma
Companies in the same business, of comparable size and area, outside its group.
- Ajaga Retail sale of pharmaceutical products Knokke-Heist · balance sheet 21,992 €
- Apotheek Vandyck Retail sale of pharmaceutical products Anderlecht · balance sheet 21,647 €
- Eklosium Retail sale of pharmaceutical products Schaerbeek · balance sheet 21,432 €
- Kasibel Retail sale of pharmaceutical products Uccle · balance sheet 20,641 €
- PharmaSave Retail sale of pharmaceutical products Antwerp · balance sheet 20,063 €
- Camille Huby Retail sale of pharmaceutical products Etterbeek · balance sheet 18,562 €
- Deropharma Retail sale of pharmaceutical products Waterloo · balance sheet 29,143 €
- Anne Longueville Retail sale of pharmaceutical products Écaussinnes · balance sheet 29,378 €
Frequently asked questions about JL Pharma
What is the revenue of JL Pharma?
JL Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of JL Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0743926553 for JL Pharma, if the company is VAT-registered. Its company number (CBE) is 0743.926.553.
Where is the registered office of JL Pharma?
According to the CBE register, the registered office of JL Pharma is in 4987 Stoumont.
What is the equity of JL Pharma?
At the close of the 2025 financial year, the equity of JL Pharma amounts to 10,746 €, a solvency of 47.5% of total assets.
Who manages JL Pharma?
The register lists 1 active mandates at JL Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of JL Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →